Ready to break through weight loss barriers
This post is sponsored by C.O
In the over 2500 participants, who were assigned to the 5, 10, and 15 mg doses of tirzepatide and placebo, the percent weight changes were both statistically and clinically significant compared with placebo
But the FDA flagged a serious adverse event, including a death, associated with an IV ipamorelin infusion (although it wasnt clear whether the peptide directly caused the participant's death)
Seek prompt medical review if you experience persistent vomiting, signs of dehydration, inability to maintain adequate oral intake, or symptoms such as unusual fatigue, muscle weakness, numbness or tingling, which may indicate nutritional deficiencies requiring investigation
Immune complexes were detected using the Immobilon Western Chemiluminescent HRP Substrate (WBKLS0050, Millipore Corporation, Billerica, MA)